Human immunodeficiency virus: What primary care clinicians need to know

Mayo Clinic Proceedings

Volumn 88, Issue 12, 2013, Pages 1468-1474

  Burgess, Mary J ^a   Kasten, Mary Jo ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; ATAZANAVIR; BENZODIAZEPINE DERIVATIVE; COTRIMOXAZOLE; DARUNAVIR; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ERECTILE DYSFUNCTION AGENT; GARLIC EXTRACT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERICUM PERFORATUM EXTRACT; HYPOCHOLESTEROLEMIC AGENT; INTEGRASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RALTEGRAVIR; RITONAVIR; TENOFOVIR; UNCLASSIFIED DRUG; WARFARIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE DISEASE; AGE; ANUS CANCER; ASEPTIC MENINGITIS; BONE MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAREGIVER; CD4 LYMPHOCYTE COUNT; CHEMILUMINESCENCE IMMUNOASSAY; CHRONIC DISEASE; CLINICAL EVALUATION; CLINICAL PRACTICE; COMORBIDITY; CONTINUING EDUCATION; DIABETES MELLITUS; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG POTENTIATION; ENZYME IMMUNOASSAY; EPIDEMIC; FEVER; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEAD AND NECK CANCER; HEADACHE; HEALTH CARE NEED; HEALTH PROGRAM; HIGH RISK BEHAVIOR; HIV TEST; HOMOSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INFECTION CONTROL; INTRAVENOUS DRUG ABUSE; KIDNEY DISEASE; LEUKOPENIA; LIFESTYLE; LIFESTYLE MODIFICATION; LIVER DISEASE; LIVER FUNCTION TEST; LUNG CANCER; LYMPHADENOPATHY; MACULOPAPULAR RASH; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RESEARCH; NEPHROTOXICITY; OPPORTUNISTIC INFECTION; OPT OUT APPROACH; OROPHARYNX CANDIDIASIS; OSTEOPOROSIS; PAPANICOLAOU TEST; PATIENT CARE; PHARYNGEAL ERYTHEMA; PHARYNX DISEASE; PRIMARY MEDICAL CARE; PROPHYLAXIS; RAPID TEST; REVIEW; SAFE SEX; SCREENING TEST; SEX DIFFERENCE; SEXUAL ABSTINENCE; SEXUAL BEHAVIOR; SKIN CANCER; SMOKING; SORE THROAT; SYMPTOMATOLOGY; TEST STRIP; THROMBOCYTOPENIA; ULCER; WESTERN BLOTTING; ADULT; AGED; AIDS RELATED COMPLEX; BONE DENSITY; CART; CDC; CENTERS FOR DISEASE CONTROL AND PREVENTION; COMBINATION ANTIRETROVIRAL TREATMENT; DIFFERENTIAL DIAGNOSIS; DISEASE MANAGEMENT; DRUG INTERACTION; FEMALE; FOOD AND DRUG ADMINISTRATION; LFT; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; NEOPLASM; PHYSICIAN ATTITUDE; PREEXPOSURE PROPHYLAXIS; PREP; PRIMARY HEALTH CARE; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTOR; STANDARD; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CARDIOVASCULAR DISEASES; COMPLICATION; HIV INFECTIONS; KIDNEY DISEASES; LIVER DISEASES; NEOPLASMS; PROCEDURES; STANDARDS; TRENDS;

CART; CDC; CENTERS FOR DISEASE CONTROL AND PREVENTION; COMBINATION ANTIRETROVIRAL TREATMENT; EIA; ENZYME IMMUNOASSAY; FDA; FOOD AND DRUG ADMINISTRATION; HIV; HUMAN IMMUNODEFICIENCY VIRUS; LFT; LIVER FUNCTION TEST; PREEXPOSURE PROPHYLAXIS; PREP;

ACUTE DISEASE; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; BONE DENSITY; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; DRUG INTERACTIONS; FEMALE; HIV INFECTIONS; HUMANS; KIDNEY DISEASES; LIVER DISEASES; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASMS; PHYSICIAN'S ROLE; PRIMARY HEALTH CARE; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS;

EID: 84892968607     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.07.010     Document Type: Review

References (25)

1. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006; 55(RR-14):1-17.
2. Moyer VA, on behalf of the U.S. Preventive Services Task Force. Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2013;159(1):51-60.
3. Work Group for HIV and Aging Consensus Project. Summary report from the Human Immunodeficiency Virus and Aging Consensus Project: treatment strategies for clinicians managing older individuals with the human immunodeficiency virus. J Am Geriatr Soc. 2012;60(5):974-979.
4. Kasten MJ. Human immunodeficiency virus: the initial physicianpatient encounter. Mayo Clin Proc. 2002;77(9):957-962; quiz 962-963.
5. Greenwald JL, Burstein GR, Pincus J, Branson B. A rapid review of rapid HIV antibody tests. Curr Infect Dis Rep. 2006;8(2): 125-131.
6. Koval CE. Home testing for HIV: hopefully, a step forward. Cleve Clin J Med. 2012;79(10):713-716.
7. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev. 2002;1: CD003255.
8. Kreiss J, Ngugi E, Holmes K, et al. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA. 1992;268(4):477-482.
9. Temesgen Z, ed. Mayo Clinic Infectious Diseases Board Review (Mayo Clinic Scientific Press). New York, NY: Oxford University Press; 2011:414.
10. Centers for Disease Control and Prevention (CDC). Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morb Mortal Wkly Rep. 2012;61(31): 586-589. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm 6131a2.htm. Accessed July 15, 2013.
11. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med. 1998;339(1):33-39.
12. Cornett JK, Kirn TJ. Laboratory diagnosis of HIV in adults: a review of current methods. Clin Infect Dis. 2013;57(5):712-718.
13. Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009; 49(5):651-681.
14. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. February 12, 2013. http://aidsinfo.nih. gov/contentfiles/ lvguidelines/AdultandAdolescentGL.pdf. Section accessed: Initiating ART in Treatment-Naive Patients. Accessed July 15, 2013.
15. Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recommen Rep. 2009;58(RR-4):1-207; quiz CE1-CE4.
16. Centers for Disease Control and Prevention (CDC). Epidemiology of HIV/AIDSdUnited States, 1981-2005. MMWR Morb Mortal Wkly Rep. 2006;55(21):589-592.
17. Kirk JB, Goetz MB. Human immunodeficiency virus in an aging population, a complication of success. J Am Geriat Soc. 2009; 57(11):2129-2138.
18. Stein JH. Cardiovascular risk and dyslipidemia management in HIV-infected patients. Top Antivir Med. 2012;20(4):129-133; quiz 123-124.
19. de Silva TI, Post FA, Griffin MD, Dockrell DH. HIV-1 infection and the kidney: an evolving challenge in HIV medicine. Mayo Clin Proc. 2007;82(9):1103-1116.
20. Kalayjian RC, Lau B, Mechekano RN, et al. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS. 2012;26(15):1907-1915.
21. Walker Harris V, Brown TT. Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies. J Infect Dis. 2012;205(suppl 3):S391-S398.
22. Price JC, Thio CL. Liver disease in the HIV-infected individual. Clin Gastroenterol Hepatol. 2010;8(12):1002-1012.
23. Mindikoglu AL, Regev A, Magder LS. Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database. Transplantation. 2008;85(3):359-368.
24. Deeken JF, Tjen-A-Looi A, Rudek MA, et al. The rising challenge of noneAIDS-defining cancers in HIV-infected patients. Clin Infect Dis. 2012;55(9):1228-1235.
25. de Maat MM, Ekhart GC, Huitema AD, Koks CH, Mulder JW, Beijnen JH. Drug interactions between antiretroviral drugs and comedicated agents. Clin Pharmacokinet. 2003;42(3): 223-282.